BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26555799)

  • 1. Sextant-Specific Analysis of Detection and Tumor Volume by HistoScanning™.
    Porres D; Kuru TH; Epplen R; Eck A; Zugor V; Kennes LN; Afram S; Braunschweig T; Knüchel-Clarke R; Pfister D; Heidenreich A
    Urol Int; 2016; 96(2):194-201. PubMed ID: 26555799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate.
    Schiffmann J; Tennstedt P; Fischer J; Tian Z; Beyer B; Boehm K; Sun M; Gandaglia G; Michl U; Graefen M; Salomon G
    World J Urol; 2014 Aug; 32(4):925-30. PubMed ID: 24871425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of perineal HistoScanning™ template-guided prostate biopsy].
    Hamann MF; Hamann C; Olzem D; Trettel A; Juenemann KP; Naumann CM
    Urologe A; 2015 Nov; 54(11):1596, 1598-601. PubMed ID: 25794587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies.
    Javed S; Chadwick E; Edwards AA; Beveridge S; Laing R; Bott S; Eden C; Langley S
    BJU Int; 2014 Oct; 114(4):541-8. PubMed ID: 24224648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prostate cancer volume measured by HistoScanning™ and final histopathological results.
    Schiffmann J; Fischer J; Tennstedt P; Beyer B; Böhm K; Michl U; Graefen M; Salomon G
    World J Urol; 2014 Aug; 32(4):939-44. PubMed ID: 24270968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy.
    Cantiello F; Russo GI; Ferro M; Cicione A; Cimino S; Favilla V; Perdonà S; Bottero D; Terracciano D; De Cobelli O; Morgia G; Damiano R
    Urol Oncol; 2015 Apr; 33(4):163.e15-23. PubMed ID: 25575715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of HistoScanning™ for the prediction of a negative surgical margin in patients undergoing radical prostatectomy.
    Salomon G; Spethmann J; Beckmann A; Autier P; Moore C; Durner L; Sandmann M; Haese A; Schlomm T; Michl U; Heinzer H; Graefen M; Steuber T
    BJU Int; 2013 Jan; 111(1):60-6. PubMed ID: 22882794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?
    Hamann MF; Hamann C; Trettel A; Jünemann KP; Naumann CM
    BMC Urol; 2015 Jul; 15():76. PubMed ID: 26223353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Histoscanning™ prior to prostate biopsy for the diagnosis of prostate adenocarcinoma.
    Núñez-Mora C; García-Mediero JM; Patiño P; Orellana C; Garrido A; Rojo A; Rendón D
    Actas Urol Esp; 2013 Jun; 37(6):342-6. PubMed ID: 23507291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histoscanning has low sensitivity and specificity for seminal vesicle invasion.
    Schiffmann J; Beyer B; Fischer J; Tennstedt P; Boehm K; Michl U; Graefen M; Salomon G
    Urology; 2014 Nov; 84(5):1168-71. PubMed ID: 25443925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. True targeting-derived prostate biopsy: HistoScanning™ remained inadequate despite advanced technical efforts.
    Schiffmann J; Mehring G; Tennstedt P; Manka L; Boehm K; Leyh-Bannurah SR; Karakiewicz PI; Hammerer P; Graefen M; Salomon G
    World J Urol; 2016 Apr; 34(4):495-500. PubMed ID: 26215749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
    Abdollah F; Scattoni V; Raber M; Roscigno M; Briganti A; Suardi N; Gallina A; Capitanio U; Freschi M; Salonia A; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2011 Aug; 108(3):366-71. PubMed ID: 21087451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion of Magnetic Resonance Imaging and Real-Time Elastography to Visualize Prostate Cancer: A Prospective Analysis using Whole Mount Sections after Radical Prostatectomy.
    Brock M; Roghmann F; Sonntag C; Sommerer F; Tian Z; Löppenberg B; Palisaar RJ; Noldus J; Hanske J; von Bodman C
    Ultraschall Med; 2015 Aug; 36(4):355-61. PubMed ID: 24854132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™).
    Simmons LA; Autier P; Zát'ura F; Braeckman J; Peltier A; Romic I; Stenzl A; Treurnicht K; Walker T; Nir D; Moore CM; Emberton M
    BJU Int; 2012 Jul; 110(1):28-35. PubMed ID: 22093966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversial evidence for the use of HistoScanning™ in the detection of prostate cancer.
    Schiffmann J; Manka L; Boehm K; Leyh-Bannurah SR; Karakiewicz PI; Graefen M; Hammerer P; Salomon G
    World J Urol; 2015 Dec; 33(12):1993-9. PubMed ID: 25860379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
    Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
    J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis of Histoscanning™ in prostate cancer diagnostics.
    Morozov A; Kozlov V; Rivas JG; Teoh JY; Bezrukov E; Amosov A; Barret E; Taratkin M; Salomon G; Herrmann TRW; Gozen A; Enikeev D;
    World J Urol; 2021 Oct; 39(10):3733-3740. PubMed ID: 33825986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.